Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
ConclusionsBoth formulations of semaglutide provided clinically and statistically significant reductions in HbA1c and weight in real-world practice. Oral GLP-1 RA may offer a practical and effective option for the management of T2D.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Statistics | Study | Wales Health